AstraZeneca PLC vs LVMH Moët Hennessy - Louis Vuitton, Société Européenne
Market cap comparison over time
AstraZeneca PLC
$246.2B
Rank #60
LVMH Moët Hennessy - Louis Vuitton, Société Européenne
$254.9B
Rank #58
Market Cap Over Time
Key Moments
- LVMH Moët Hennessy - Louis Vuitton, Société Européenne overtook AstraZeneca PLC by 2010
- AstraZeneca PLC overtook LVMH Moët Hennessy - Louis Vuitton, Société Européenne by 2013
- LVMH Moët Hennessy - Louis Vuitton, Société Européenne overtook AstraZeneca PLC by 2016
Year-by-Year Comparison
| Year | AstraZeneca PLC | LVMH Moët Hennessy - Louis Vuitton, Société Européenne | Leader |
|---|---|---|---|
| 2026 | $246.2B | $254.9B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2025 | $282.2B | $335.8B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2024 | $196.9B | $322.8B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2023 | $198.1B | $366.2B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2022 | $195.3B | $334.5B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2021 | $163.9B | $353.6B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2020 | $136.9B | $244.8B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2019 | $132.8B | $196.1B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2018 | $97.9B | $120.0B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2017 | $85.9B | $111.9B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2016 | $64.5B | $81.7B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2015 | $76.6B | $63.2B | AstraZeneca PLC |
| 2014 | $76.2B | $56.5B | AstraZeneca PLC |
| 2013 | $61.7B | $55.9B | AstraZeneca PLC |
| 2012 | $46.3B | $57.2B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2011 | $42.7B | $44.0B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2010 | $40.3B | $48.6B | LVMH Moët Hennessy - Louis Vuitton, Société Européenne |
| 2009 | $38.9B | $30.3B | AstraZeneca PLC |
| 2008 | $32.3B | $18.0B | AstraZeneca PLC |
| 2007 | $32.3B | $30.3B | AstraZeneca PLC |
| 2006 | $39.1B | $28.6B | AstraZeneca PLC |
| 2005 | $34.5B | $26.5B | AstraZeneca PLC |
| 2004 | $25.2B | $19.5B | AstraZeneca PLC |
| 2003 | $32.9B | $19.7B | AstraZeneca PLC |
| 2002 | $23.4B | $13.1B | AstraZeneca PLC |
| 2001 | $30.5B | $15.1B | AstraZeneca PLC |
| 2000 | $33.1B | $23.0B | AstraZeneca PLC |